பஃபெட் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பஃபெட் புற்றுநோய் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பஃபெட் புற்றுநோய் மையம் Today - Breaking & Trending Today

AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients .
AIM ImmunoTech Inc.February 10, 2021 GMT
OCALA, Fla., Feb. 10, 2021 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Dutch Health and Youth Care Inspectorate (IGJ) has approved treatment for six pancreatic cancer patients as part of a new, follow-up Early Access Program (EAP) at Erasmus Medical Center in the Netherlands. Subject to further authorization we plan to treat up to 16 pancreatic cancer patients with rintatolimod (Ampligen) under the EAP, which follows the success of a previous multi-year Ampligen EAP for pancreatic cancer patients at Erasmus MC. The new approval was designed to include several patients treated under the previous EAP, who are still alive despite their diagnoses several years ago of locally advanced or metastatic pancr ....

United States , Hemispherx Biopharma Europe , Casper Van Eijck , Dutch Health , Immunotech Inc , Crescendo Communications , European Commission , Drug Administration , Buffett Cancer Center , Early Access Program , University Of Nebraska Medical Centerk Klute , European Union , European Medicines Agency , Erasmus Medical Center , Youth Care Inspectorate , Both Erasmus , Nebraska Medical Center , Orphan Drug Designation , Investigational New Drug , Clinical Trial Application , Fast Track , Private Securities Litigation Reform Act , Medicinal Production Designation , Tech Inc , Products And Services , Pancreatic Cancer ,